Genpact Limited Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Genpact Limited (G) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $9.28 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2019-08-09
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was -$38.08M.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was -$81.53M.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was -$39.99M.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2016-03-31 was -$20.68M.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was -$71.73M, a 261.99% decline from fiscal 2017.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was $44.28M.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was -$12.79M.
- Genpact Limited cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2014 was -$98.40M, a 158.64% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | $9.28M 10-Q · filed 2019-08-09 | ||||
| 2019-03-31 | -$38.08M 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | -$71.73M 10-K · filed 2019-03-01 | ||||
| 2018-09-30 | -$49.02M 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | -$146.17M 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | -$81.53M 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $44.28M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | -$11.42M 10-Q · filed 2018-11-09 | ||||
| 2017-06-30 | -$2.15M 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | -$39.99M 8-K · filed 2018-06-04 | ||||
| 2016-12-31 | -$12.79M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$29.25M 10-Q · filed 2017-11-09 | -$29.24M 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | -$35.94M 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | -$20.68M 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $8.08M 8-K · filed 2018-06-04 | ||||
| 2015-09-30 | $22.37M 10-Q · filed 2016-11-08 | ||||
| 2015-06-30 | -$9.12M 10-Q · filed 2016-08-08 | ||||
| 2015-03-31 | -$23.29M 10-Q · filed 2016-05-09 | ||||
| 2014-12-31 | -$98.40M 10-K · filed 2017-03-01 | ||||
| 2013-12-31 | $167.82M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |